New Antithrombotic Strategies: Do They Increase Clinical Benefits?

 

 

 

By: Dr. Gustavo Olmedo F., FESC – FACC
Departamento de cardiologia
Hospital de Clínicas

Important:

The intellectual property rights to the presentations and content available on this website belong to their respective owners and/or SOLACI. Their publication on SOLACI is carried out under strict authorization for scientific, medical, and educational purposes. Any reproduction, distribution, modification, or other use is expressly prohibited without the prior written consent of the rights holders and/or SOLACI.

More articles by this author

Current Indications for Statins According to Age Groups and Associated Risk Factors

    Por: Dr. Jorge Enrique Solano-López F.A.C.P Important: The intellectual property rights to the presentations and content available on this website belong to their respective owners and/or...

Surgical Aortic Valve Replacement: PARTNER 5-Year Results

    By: Fabio B. Jatene Full Professor of Cardiovascular Surgery, Medical School, University of São Paulo, Brazil Important: The intellectual property rights to the presentations and content available on...

Severe Aortic Stenosis With Low Flow, Low Gradient, and Systolic Dysfunction

  By: Rubén G. Servián C. MD Departamento de Imágenes – Hospital Central Instituto de Previsión Social (I.P.S.) Important: The intellectual property rights to the presentations and content available...

Cardiovascular Disease Prevention and Physical Exercise in Adults: Is It a Matter of Intensity?

    By: Dra. María Carolina Acosta Cazal Important: The intellectual property rights to the presentations and content available on this website belong to their respective owners and/or...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is abdominal aortic aneurysm screening cost-effective in women?

Although ultrasound screening for abdominal aortic aneurysm (AAA) is a well-established strategy in men over 65 years of age, its value in women remains...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...